Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adjuvant therapy in resectable gastric cancer.

Literature DB >> 1457367

Adjuvant therapy in resectable gastric cancer.

H Bleiberg¹, B Gerard, P Deguiral.

Abstract

Entities: Disease

Mesh：

Year: 1992 PMID： 1457367 PMCID： PMC1978050 DOI： 10.1038/bjc.1992.399

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

× No keyword cloud information.

40 in total

1. Randomized controlled study of postoperative adjuvant immunochemotherapy with Nocardia rubra cell wall skeleton (N-CWS) and Tegafur for gastric carcinoma.

Authors: S Koyama; A Ozaki; Y Iwasaki; T Sakita; T Osuga; A Watanabe; M Suzuki; T Kawasaki; T Soma; T Tabuchi
Journal: Cancer Immunol Immunother Date: 1986 Impact factor: 6.968

2. Adjuvant chemotherapy in gastric cancer.

Authors: P Schlag
Journal: World J Surg Date: 1987-08 Impact factor: 3.352

3. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.

Authors: C G Moertel; D S Childs; R J Reitemeier; M Y Colby; M A Holbrook
Journal: Lancet Date: 1969-10-25 Impact factor: 79.321

4. Effect of cimetidine on survival after gastric cancer.

Authors: H Tønnesen; U Knigge; S Bülow; P Damm; K Fischerman; P Hesselfeldt; A Hjortrup; I K Pedersen; V M Pedersen; O J Siemssen
Journal: Lancet Date: 1988-10-29 Impact factor: 79.321

5. Postoperative immunochemotherapy (BCG + 5-FU) in advanced gastric cancer.

Authors: T Popiela; M Zembala; J Kulig; A Czupryna; W Uracz
Journal: Anticancer Res Date: 1988 Nov-Dec Impact factor: 2.480

6. Natural history of "early" gastric cancer: results of a 10-year regional survey.

Authors: J W Fielding; D J Ellis; B G Jones; J Paterson; D J Powell; J A Waterhouse; V S Brookes
Journal: Br Med J Date: 1980-10-11

7. An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer.

Authors: J Wils; H Bleiberg; O Dalesio; G Blijham; N Mulder; A Planting; T Splinter; N Duez
Journal: J Clin Oncol Date: 1986-12 Impact factor: 44.544

8. Gastric cancer: a 25-year review.

Authors: W H Allum; D J Powell; C C McConkey; J W Fielding
Journal: Br J Surg Date: 1989-06 Impact factor: 6.939

9. Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

Authors: P F Engstrom; P T Lavin; H O Douglass; K W Brunner
Journal: Cancer Date: 1985-05-01 Impact factor: 6.860

Review 10. Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy.

Authors: W J Cunliffe; P H Sugarbaker
Journal: Br J Surg Date: 1989-10 Impact factor: 6.939

6 in total

Review 1. Gastric cancer.

Authors: P McCulloch
Journal: Postgrad Med J Date: 1996-08 Impact factor: 2.401

Review 2. Diagnosis and treatment of gastric cancer.

Authors: A Hendlisz; H Bleiberg
Journal: Drugs Date: 1995-05 Impact factor: 9.546

3. Histopathological assessment of multidrug resistance in gastric cancer: expression of P-glycoprotein, multidrug resistance-associated protein, and lung-resistance protein.

Authors: D Alexander; T Yamamoto; S Kato; S Kasai
Journal: Surg Today Date: 1999 Impact factor: 2.549